Episode 323: Journal Club Including Discussion of Implicit Bias in Residency Applications, Trends in Venture Capital Investments in Ophthalmology Companies and more

Drs. Marianeli Rodriguez and Akshay Thomas join for a journal club style discussion of four recent publications in high-impact ophthalmology journals.

• Implicit Bias in Residency Applications
• Venture Capital Investments in Ophthalmology
• Physician-Industry Relationships and KOL
• Racial Differences in Glaucoma Care

Financial Disclosures:
Dr. Sridhar is a consultant for Alcon, Allergan, Dorc, Genentech, and Regeneron. Dr. Rodriguez has no relevant disclosures.

CME Information

Release: December 8, 2021; expires December 8, 2024

Reviewers: D. Wilkin Parke III, MD

Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.